Up to $2900


Nektar – Lupus

Official Title

A Study of NKTR-358 in Participants With Systemic Lupus Erythematosis (SLE)

Study Summary

The main purpose of this study is to evaluate the safety and tolerability of a study drug known as NKTR-358 in participants with SLE.

Eligibility and Recruitment Information

Recruitment Status Recruiting
Eligible Genders Both
Eligible Ages 18-70
Inclusion Diagnosis of adult SLE. Minimal to moderate SLE disease activity
Exclusion Evidence of significant liver or kidney dysfunction
Start Date
Compensation Up to $2900
Location Orlando, FL

Study Information

Condition Lupus

Administrative Information

Study ID NCT03556007

Apply for this study

Please include your first name.
Please include your last name.
Please include a valid email address.
Thank you for applying.
Sorry, something wen't wrong. Please contact us for support.